PN precluded NF-κB nuclear translocation and activation as well as BCL-XL up-regulation caused by paclitaxel in human lung cancer cell lines sensitive (A549, NCI-H446) and resistant (A549-T24) to paclitaxel [80]. Here, NFKB1 is linked to lung cancer.